Three years into your first job with a nine-physician orthopedic group, the managing partner slides a one-page term sheet across the table. Buy-in: $340,000. Payable over four years from pre-tax distributions. The number arrives with no schedule of what it purchases, no explanation of how it was derived, and a strong implication that asking is impolite.
Ask anyway. A buy-in is a purchase of an asset, and no physician would accept a $340,000 asset purchase in any other context without an itemized description of the asset. The number itself is also the smaller half of the analysis. The buy-in price determines what you pay; the compensation formula, the payment structure, and the buy-out terms determine whether you ever get it back.
There are three ways to value a practice, and every credible appraisal uses more than one
Professional valuation standards recognize three approaches. The AICPA Statement on Standards for Valuation Services No. 1, issued in June 2007 and effective for engagements accepted on or after January 1, 2008, names them: the income approach, the asset-based approach (also called the cost approach), and the market approach.
Asset-based. Add up what the practice owns and subtract what it owes. For a physician practice this means hard assets at fair market value rather than depreciated book value — imaging equipment, surgical instruments, leasehold improvements, furniture — plus accounts receivable adjusted to what will actually be collected, minus liabilities including equipment notes, the lease obligation, and any deferred compensation owed to existing partners. This is the floor. A practice cannot credibly be worth less than its net tangible assets, and it is frequently worth barely more.
Income or capitalization. Take normalized earnings, subtract a reasonable return on the tangible assets, and treat the remainder as earnings attributable to intangibles, then capitalize that remainder. Rev. Rul. 68-609, 1968-2 C.B. 327 sets out the classic formula version: deduct a return on the average annual value of tangible assets (using the industry percentage, "or (when the industry percentage is not available) a percentage of 8 to 10 percent may be used"), and capitalize the remaining earnings "at a percentage of, say, 15 to 20 percent." The ruling pairs 8 percent return with 15 percent capitalization for stable, low-risk businesses and 10 percent with 20 percent where "the hazards of business are relatively high."
Critically, that same ruling instructs that for a partnership or sole proprietorship "there should be deducted from the earnings of the business a reasonable amount for services performed by the owner or partners engaged in the business." This single sentence dismantles most physician practice goodwill claims. If the partners are paid market compensation for the medicine they personally perform, the residual earnings available to capitalize are often near zero.
Market. What comparable practices actually sold for. In practice this is the weakest leg for a private physician group, because transactions are private, rarely disclosed, and structured so differently that comparability is thin.
Important
Rev. Rul. 68-609 is explicit that the formula approach is a method of last resort: "The 'formula' approach should not be used if there is better evidence available from which the value of intangibles can be determined," and it "may be used for determining the fair market value of intangible assets of a business only if there is no better basis therefor available." A buy-in priced by applying a rule-of-thumb multiple to collections is not a valuation. It is a negotiating anchor wearing a valuation's clothing.
Professional goodwill in a personal-services practice is worth less than the term sheet claims
The largest line in most buy-in numbers is goodwill, and physician practice goodwill is unusually fragile because it is attached to people rather than to the entity.
Rev. Rul. 59-60, 1959-1 C.B. 237 — the foundational IRS valuation ruling, listing eight factors including "whether or not the enterprise has goodwill or other intangible value" — grounds goodwill in earnings: "In the final analysis, goodwill is based upon earning capacity. The presence of goodwill and its value, therefore, rests upon the excess of net earnings over and above a fair return on the net tangible assets."
The tax courts then draw the line that matters most here. In Norwalk v. Commissioner, T.C. Memo. 1998-279, involving the liquidation of an accounting firm, the court held that the goodwill of a professional service corporation belongs to the individual professionals unless they "enter into a covenant not to compete with the corporation or other agreement whereby their personal relationships with clients become property of the corporation." Martin Ice Cream Co. v. Commissioner, 110 T.C. 189 (1998) reached the parallel conclusion that "personal relationships of a shareholder-employee are not corporate assets when the employee has no employment contract with the corporation."
The operative rule for a physician evaluating a buy-in: enforceable employment agreements and non-competes are what convert personal goodwill into enterprise goodwill. Absent them, the referring-physician relationships and patient loyalty walk out with the individual surgeon, and the entity does not own them.
Key insight
Two diagnostic questions cut through most goodwill arguments. First: if the three highest-producing partners left tomorrow, how much of the practice's revenue survives? Second: are those partners bound by enforceable non-competes? A practice whose value rests on institutional assets — a certificate of need, an ambulatory surgery center interest, a favorable long-term lease, a payer contract that runs with the entity, a durable ancillary line — has genuine enterprise goodwill. A practice whose value rests on the partners' own reputations is asking you to buy something it does not own.
Fair market value is not merely prudent here, it is regulated territory
Physician compensation and ownership arrangements sit inside a regulatory framework that treats valuation as a compliance matter, not just a business one. This is awareness-level context, not legal advice, and the analysis for a genuine intra-group partnership buy-in differs from the analysis for a hospital or health system acquiring a practice.
The physician self-referral statute, 42 U.S.C. §1395nn, conditions its principal compensation exceptions on fair market value — rental of office space and equipment, bona fide employment, and personal service arrangements each require compensation consistent with or not exceeding fair market value and not determined in a manner that takes into account the volume or value of referrals. The 2020 "Modernizing and Clarifying the Physician Self-Referral Regulations" final rule (85 Fed. Reg. 77492, published December 2, 2020, effective January 19, 2021) replaced the prior definition with a three-prong structure at 42 CFR §411.351 and added a separate defined term, "general market value."
The federal Anti-Kickback Statute, 42 U.S.C. §1320a-7b(b), prohibits knowingly and willfully soliciting, receiving, offering, or paying "any remuneration (including any kickback, bribe, or rebate) directly or indirectly, overtly or covertly, in cash or in kind" to induce referrals or the purchase of federally reimbursable items or services. Safe harbors appear at 42 CFR §1001.952, including investment interests at (a), personal services at (d), and investments in group practices at (p).
Two cautions belong here. First, HHS OIG's 1992 letter on physician practice acquisitions warns that where a buyer is in a position to benefit from referrals, "any amount paid in excess of the fair market value of the hard assets of a physician practice would be open to question," flagging goodwill, covenants not to compete, and patient lists specifically. That letter addresses a referral-generating buyer such as a hospital, not physicians buying into their own group, so do not over-read it. Second, an OIG FAQ added April 23, 2026 states that "an arrangement may violate the Federal anti-kickback statute even where it involves remuneration consistent with fair market value," and that a financial arrangement can satisfy a Stark exception yet still violate the Anti-Kickback Statute. Fair market value is a necessary discipline, not a safe harbor by itself.
The payment structure decides the actual cost more than the price does
The same $340,000 has three very different economics depending on how it is paid.
| Structure | Mechanism | What to check |
|---|---|---|
| Cash at closing | You write a check, financed personally | After-tax dollars. A $340,000 buy-in requires roughly $566,000 of pre-tax income at a 40% combined |
| Promissory note | You sign a note to the practice or to the selling partners | The interest rate, whether interest is deductible, whether the note is recourse, and what happens to the balance if you leave |
| Earnings withhold | The practice reduces your distributions until the buy-in is satisfied | Whether the withhold is pre-tax or post-tax to you, and whether the reduction is measured against the partner formula or your associate salary |
| Sweat equity | Below-market compensation for a defined period counts as the buy-in | Whether the discount is documented and capped, and whether it terminates automatically on a date certain |
The earnings-withhold structure is the most common and the most frequently misunderstood. If your compensation formula at partnership would have paid $610,000 and the practice pays you $525,000 during a four-year buy-in period, you have paid $340,000 — and whether that is more or less painful than a cash purchase depends entirely on whether the reduction happens before or after tax, which is a question for the partnership agreement and your accountant, not the managing partner's summary.
Example calculation
Assumptions, stated explicitly: a nine-physician orthopedic group. Buy-in $340,000 via earnings withhold over four years. Current associate compensation $480,000. Partner compensation under the formula, before the withhold, $640,000. Combined federal and state marginal rate 40 percent. No change in clinical volume or call burden.
Annual income delta at partnership, before buy-in: $640,000 minus $480,000 = $160,000 per year
Annual withhold: $340,000 over 4 years = $85,000 per year
Net cash improvement during the buy-in period: $160,000 minus $85,000 = $75,000 per year, or $300,000 over four years
Net improvement after the buy-in is complete: $160,000 per year
Simple payback on the buy-in, measured against the income delta: $340,000 / $160,000 = 2.1 years of the income delta
Same practice, alternative fact pattern: partner compensation under the formula is $545,000, not $640,000, because the partner formula shifts overhead allocation onto partners.
Annual income delta: $545,000 minus $480,000 = $65,000 Annual withhold: $85,000 Net cash during the buy-in period: negative $20,000 per year Simple payback: $340,000 / $65,000 = 5.2 years
Identical buy-in price. One version returns the purchase price in roughly two years of income delta; the other takes more than five and requires you to earn less than you do now for four of them. The price was never the variable that mattered.
Never evaluate a buy-in price without the partner compensation formula in writing, because the price is meaningless until you know what the income on the other side of it is. Request the last three years of actual partner distributions, not the projection.
Ask what you are buying, and check whether the buy-out is symmetric
Two questions expose more than any valuation report.
What exactly does the price purchase? Ask for a schedule: hard assets at appraised value, accounts receivable at a collection-adjusted rate, real estate or surgery center interests held separately, and goodwill stated as a residual. Watch the accounts receivable line specifically. If a meaningful portion of the buy-in purchases equity in receivables, ask whose work generated them. Buying into a pool of receivables that your own future production will replenish is different from buying into an asset that generates returns independent of your labor. Net collection ratios in the mid-to-high nineties and A/R over 90 days in the low-to-mid teens circulate widely as industry benchmarks but trace only to secondary commentary rather than a retrievable primary publication, so use the practice's own audited collection history rather than a benchmark.
Is the buy-out formula symmetric with the buy-in? This is the single most informative test available, and it takes ten minutes. Apply the buy-out formula in the partnership agreement to a hypothetical partner leaving today, then apply the buy-in formula to yourself. If you are paying goodwill on the way in and receiving only book value of tangible assets on the way out, the partnership has told you what it privately believes the goodwill is worth. If the buy-out is payable over ten years without interest while the buy-in is due over four, the same message arrives in a different form. Read the buy-out provisions for the events that trigger a reduced payout — departure to a competing practice within the market, retirement before a stated age, involuntary termination — and ask who votes on involuntary termination and by what majority.
Quick takeaway
Evaluate a buy-in in this order: what the price buys (itemized, with goodwill as a residual), what the compensation formula pays on the other side (three years of actual distributions), how the payment is structured and taxed, and whether the buy-out mirrors the buy-in. A practice that will not produce the partnership agreement and three years of partner distributions before you commit has answered the most important question already.
Common questions
Is a buy-in price expressed as a multiple of collections legitimate?
Rules of thumb are anchoring devices, not valuations. Rev. Rul. 68-609 states directly that the formula approach itself should be used only when no better evidence exists, and a collections multiple is considerably cruder than that formula. Treat any multiple as a starting point that must be reconciled to an asset schedule and to normalized earnings after a reasonable charge for the partners' own services. The broader question of when to pay for an independent appraisal, and how to judge the appraiser, is covered in evaluating advisors.
Should I hire my own attorney, or is the practice's counsel sufficient?
The practice's counsel represents the practice. In a buy-in, the practice is the counterparty. An independent review of the partnership agreement, the buy-out provisions, the compensation formula, and the restrictive covenant is one of the few professional fees in a physician's career with an obvious return, and when a contract lawyer is worth it works through the threshold.
What if the partners refuse to share historical distributions?
That is an answer. Confidentiality concerns are addressable with a nondisclosure agreement and aggregated or anonymized figures. A refusal that survives those accommodations tells you either that the numbers do not support the offer or that the group's information culture will not improve after you sign. Neither is a reason to proceed on faith.
Does buying in always beat staying an associate or starting my own practice?
No. Partnership makes sense when the income delta is large, durable, and supported by assets you could not replicate — an established referral base tied to institutional contracts, an ancillary revenue stream, or a surgery center interest. Where the delta is thin and the practice's value is essentially the partners' personal reputations, the capital and risk may do more elsewhere. The comparison against building your own is laid out in practice ownership economics, and the W-2-versus-ownership economics are priced in W-2 or 1099.
What to do next
- Request, in writing, an itemized schedule of what the buy-in price purchases: hard assets at appraised value, accounts receivable at a collection-adjusted rate, separately held real estate or ancillary interests, and goodwill as a stated residual. This costs one email and reveals the most.
- Request the partner compensation formula and three years of actual partner distributions, not a projection. Calculate your income delta at partnership.
- Divide the buy-in by that annual income delta to get the simple payback period, then rerun it with a 15 percent lower delta to test how sensitive the answer is.
- Apply the buy-out formula in the partnership agreement to a hypothetical departure today and compare it to the buy-in formula. Note every asymmetry and every event that triggers a reduced payout.
- Determine the tax character of the payment structure — pre-tax withhold, after-tax note, deductible interest — with your own accountant before agreeing to a schedule.
- Have independent counsel review the partnership agreement, the restrictive covenant, and the involuntary-termination provisions, including who votes and at what threshold.
- If goodwill exceeds roughly a quarter of the total price, commission an independent valuation. At that level the fee is small relative to the amount in dispute, and the regulatory framework around physician ownership arrangements makes a defensible fair market value analysis worth having on file.
A partnership buy-in is the largest single financial decision most physicians make between medical school debt and retirement, and it is routinely evaluated on a one-page term sheet in a hallway conversation. The discipline required is not sophisticated: itemize the asset, quantify the income on the other side, read the exit before you sign the entrance, and pay for one independent opinion. The protocol above works with or without us. This is education, not individualized financial advice.